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Abstract: Objective: To compare the platelet concentration obtained after 
application of the protocol of plasma rich in growth factors - universal 1 
(PRGF-U1) and the protocol of Anitua and Andia (PRP-A) for obtaining 
platelet rich plasma. Material and Method: A descriptive, cross-sectional and 
comparative study was carried out with a simple random probabilistic sam-
ple consisting of 16 patients who attended the Periodontics service of the 
Unit of Second Specialization in Stomatology of the National University 
of Trujillo. Five blood samples were obtained from each patient, after appl-
ying a health questionnaire to rule out any disease or drug consumption, in 
order to obtain the baseline platelet concentration and that obtained after 
PRGF-U1 and PRP-A. To compare the platelet concentrations of the two 
protocols, Student’s t-test was used considering a significance level of p<0.05. 
RESULTS: The baseline platelet concentration was 371,250±68,203 plate-
lets/μL, for PRGF-U1 it was 747,875±121,645 platelets/μL and for PRP-A 
it was 595,000±129,202 platelets/μL. A statistically significant difference 
(p<0.001) was found between both protocols. Conclusion: The PRGF-U1 
protocol yielded a higher platelet concentration compared to the Anitúa and 
Andía protocol. 
Keywords: platelet rich plasma, platelet-derived growth factors, platelet count, 
regenerative medicine.
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INTRODUCTION.
The concept of stimulation and maximization of healing 
mechanisms has gained prominence over the last years. In order 
to minimize the aftermath of invasive surgical treatments several 
methods have appeared. One of them is the platelet rich plasma 
(PRP) or plasma rich in growth factors (PRGF) that is a rich source 
of growth factors (GF).1,2 PRP is a gel containing autologous human 
platelets concentrate (at concentrations higher than plasma levels) in 
a small volume of plasma. PRP is a source of easy access to GF, which 
are secreted by the platelets when the healing process begins, allowing 
the acceleration and improving the processes of healing and tissue 
regeneration.1,2
The techniques for obtaining the PRP vary in the number of 
centrifugation steps the speed of centrifugation and the use of calcium 
chloride or other substances for their activation.1,3,4 One of the most 
used protocols and that is considered the gold standard for obtaining 
PRP is that proposed by Anitua and Andia, which has shown good 
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clinical results in improving the healing of hard and 
soft tissues.1,3-5 This protocol obtains the PRP by 
means of a single centrifugation at 1800 revolutions per 
minute (rpm) for 8 minutes producing 280g (relative 
centrifugal force or RCF).1-3,6
Marx et al.,7 claim that the PRP obtained with a 
single centrifugation does not produce a true therapeutic 
concentrate because the red cells interfere with the 
separation of the platelets. However, other authors 
do not recommend a two-step centrifugation because 
there is a risk of excessive manipulation, which leads to 
contamination or premature activation of platelets and 
loss of GF.1-3,6
Currently there is a problem with the commercial 
kits because they include centrifuges already calibrated, 
having as main disadvantage their high cost, without 
the possibility of using other centrifuges. The aim of 
this study was to compare the platelet concentration 
obtained by using the plasma protocol rich in growth 
factors-universal 1 (PRGF-U1) and by the protocol 
of Anitua and Andia (PRP- A) for the production of 
platelet rich plasma.
MATERIALS AND METHODS.
This is a cross-sectional study carried out in the Unit 
of Second Specialization in Stomatology (USSS) and in 
the Laboratory of University Welfare of the Universidad 
Nacional de Trujillo (UNT). It was approved by the 
Committee of Permanent Bioethics Research of the 
Faculty of Medicine of the UNT. The sample consists 
of  16 patients who attended the Periodontics service of 
the USSS. 
Selection criteria
Patients older than 18 years who had a good 
periodontal and general health status (evaluated by 
a resident of the USSS, previously calibrated by a 
periodontist, and through a health questionnaire) were 
included. Those who consumed medication, had blood 
parameters outside the normal range, pregnant women, 
and those who had any mental condition that made 
communication impossible were excluded.
Blood sample
Five peripheral blood samples were drawn from each 
fasting patient by a trained laboratory technician using 
the vacutainer system: One sample in EDTA test tubes 
(basal sample), two samples in test tubes with 3.8% 
sodium citrate (PRP-A), and two samples in test tubes 
with 3.2% sodium citrate (PRGF-U1), each with a 
capacity of approximately 4.5ml. 
Protocols
The baseline sample was immediately analyzed and the 
other samples were processed according to each protocol. 
The formula (RCF=1.12xRadiusx (rpm/1000)2) was 
used to calculate the rpm corresponding to 280g for the 
centrifuge (Heraeous Labofuge 200r, Daigger, USA) 
with fixed rotor at 45° and a radius of 7.7cm, resulting 
in 1800rpm for 8 minutes for the PRP-A, which was 
carried out at room temperature. (Heraeous Labofuge 
200r, Daigger, USA) with a radius of 7.7cm.1-3,6  For the 
PRGF-U1 a centrifugation of 1600rpm for 7 minutes 
was carried out at room temperature in a centrifuge 
with a rotor radius of 9.8cm (Heraeous Labofuge 200r, 
Daigger, USA).
The PRP was extracted as follows: The topmost 0.5ml 
(PPP) were removed first, f loowed by the middle 0.5ml 
(plasma under normal conditions), and finally 0.3ml 
were removed from the bottom of the tube (PRP), using 
an automatic micropipette. 
Then 0.1ml of the PRP sample for each protocol were 
taken to a Newbauer Chamber and Thomas pipette to 
obtain the platelet concentration. Each micropipette 
step was performed by a single person calibrated for this 
purpose. The remaining PRP sample was processed for 
use in scheduled surgery.
Statistical analysis 
Data were processed in the SPSS 23.0 statistical 
package (IBM, SA). To compare platelet concentrates, t 
test was used with a significance level of p<0.05.
RESULTS.
The baseline platelet concentration was 371,250± 
68,203 platelets/μL, for PRGF-U1 it was 747,875±121,645 
platelets/μL and for PRP-A it was 595,000±129,202 
platelets/μL. 
A statistically significant difference (p<0.001) was 
found between both protocols.
Beltrán K & Cardona W.
Comparative performance of the protocol of plasma rich in growth factors - universal 1 (PRGF-U1) for obtaining platelet rich plasma.
J Oral Res 2017; 6(1): 16-18. doi:10.17126/joralres.2017.006
ISSN Online 0719-2479 - www.joralres.com © 201718
Authors Procedure First Centrifugation /  Time Platelet  
  Second Centrifugation (minutes) concentration 
  (rpm/RCF)  (platelet/µL±SD)
 Mazzocca et al., (2012)7 Arthrex ACP Double Syringe System 1500 rpm 5 378,300±58,640
 Manual 1500 rpm 5 447,700±183,750
  6300 rpm 20 
Anitua et al.,  (2011)8 PRGF - Endoret 580 g 8 663,000
Sundman et al., (2011)7 Arthrex ACP Double Syringe System 1500 rpm 5 361,000±87,000
 Biomet GPS III Mini Platelet Concentrate 3200 rpm 15 701,000±473,000
 Separation Kit
Castillo et al.,  (2010)7 MTF Cascade 1100 g 6 443,800±24,700
 Biomet GPS III Mini Platelet Concentrate 1100 g 15 566,200±292,600
 Separation Kit
Mazzucco et al., (2009)7 Regen PRP - Kit 1500 g 10 430,000±109,000
Mazzucco et al.,  (2008)7 Plateltex 180 g 10 338,700±73,569
  1000 g 10 
Sánchez et al., (2007)9 PRGF System II 460 g 8 634,000±217,000
Everts et al.,  (2006)7 Biomet GPS The Gravitational Platelet 3200 rpm 12 569,000±247,000
 Sequestration System
Leitner et al., (2006)7 Fibrinet System Cascade 1000 g 15 399,000±26,627
De Obarrio et al., (2000)10 Manual 5600 rpm 6 12,500
DISCUSSION.
The results of this research show that higher platelet 
concentrations are obtained with the PRGF-U1 protocol 
and these are in turn higher than those found by other 
authors, as shown in Table 1.7-10 Thus, we believe that this 
new protocol could lead to clinical improvements since 
having a higher concentration of platelets should result in a 
greater clinical benefit.
Despite the limitations of the manual method used in 
this protocol, the previous calibration of the centrifuge and 
the use of a lower concentration of sodium citrate are fac-
tors that could improve the platelet concentration in PRP. 
Furthermore, any centrifuge may be employed during the 
protocol by using the mathematical formula to calculate 
rpm, without the need of using a commercial kit.
However, more studies are needed to compare this pro-
tocol with others, verifying the quality of the product and 
its effectiveness in laboratory and clinical settings.
CONCLUSION.
The PRGF-U1 protocol resulted in a higher platelet con-
centration compared to Anitúa and Andía protocol.
Table 1. Platelet concentrations obtained by PRP protocols.
rpm= revolutions per minute; RCF = Relative centrifugal force; SD = standard deviation
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